Interferon‐α: A new target for therapy in systemic lupus erythematosus?
Open Access
- 11 September 2003
- journal article
- editorial
- Published by Wiley in Arthritis & Rheumatism
- Vol. 48 (9) , 2396-2401
- https://doi.org/10.1002/art.11226
Abstract
No abstract availableThis publication has 41 references indexed in Scilit:
- Type-I Interferon Receptor Deficiency Reduces Lupus-like Disease in NZB MiceThe Journal of Experimental Medicine, 2003
- Interferon and Granulopoiesis Signatures in Systemic Lupus Erythematosus BloodThe Journal of Experimental Medicine, 2003
- Activation of Natural Interferon-α Producing Cells by Apoptotic U937 Cells Combined with Lupus IgG and its Regulation by CytokinesJournal of Autoimmunity, 2001
- Presence of cutaneous interferon-a producing cells in patients with systemic lupus erythematosusLupus, 2001
- Induction of Fas Ligand-Mediated Apoptosis by Interferon-αClinical Immunology, 2000
- Serum activity that confers acid lability to α‐interferon in systemic lupus erythematosus: its association with disease activity and its independence from circulating α‐interferonArthritis & Rheumatism, 1990
- Possible induction of systemic lupus erythematosus by interferon‐α treatment in a patient with a malignant carcinoid tumourJournal of Internal Medicine, 1990
- Interferon-induced 2'-5' adenylate synthetase in vivo and interferon production in vitro by lymphocytes from systemic lupus erythematosus patients with and without circulating interferon.The Journal of Experimental Medicine, 1983
- Systemic Lupus Erythematosus: Presence in Human Serum of an Unusual Acid-Labile Leukocyte InterferonScience, 1982
- Immune Interferon in the Circulation of Patients with Autoimmune DiseaseNew England Journal of Medicine, 1979